Jpmorgan Chase & CO Eloxx Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.15 - $7.2 $6 - $331	46 Added 112.2%	87 $0
Q2 2022 Aug 11, 2022	SELL	$0.24 - $0.58 $139 - $336	-581 Reduced 93.41%	41 $0
Q1 2022 May 11, 2022	BUY	$0.4 - $0.72 $232 - $418	581 Added 1417.07%	622 $0
Q3 2021 Nov 12, 2021	BUY	$1.22 - $2.0 $50 - $82	41 New	41 $0

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.